A cybernetic model to predict the effect of freely available nitrogen substrate on rifamycin B production in complex media

Applied Microbiology and Biotechnology

Volumn 72, Issue 4, 2006, Pages 662-670

  Bapat, Prashant M ^a   Sohoni, Sujata V ^a   Moses, Tessa A ^a   Wangikar, Pramod P ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMYCOLATOPSIS MEDITERRANEI; CYBERNETIC MODEL; NITROGEN CATABOLITE; NITROGEN SUBSTRATE;

AMINO ACIDS; CONCENTRATION (PROCESS); CYBERNETICS; METABOLITES; NITROGEN; OPTIMIZATION;

SUBSTRATES;

AMINO ACID; NITROGEN; PEPTIDE; PROTEIN; RIFAMYCIN B;

FERMENTATION; MODEL VALIDATION; NITROGEN; SECONDARY METABOLITE;

ARTICLE; BACTERIUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYBERNETICS; DRUG MANUFACTURE; DRUG SYNTHESIS; ENZYME MECHANISM; GROWTH; INDUSTRY; NITROGEN AVAILABILITY; NITROGEN CONCENTRATION; NOCARDIA MEDITERRANEA; NONHUMAN; PREDICTION; PRODUCT DEVELOPMENT;

ACTINOMYCETALES; CULTURE MEDIA; MODELS, BIOLOGICAL; NITROGEN; RIFAMYCINS;

AMYCOLATOPSIS MEDITERRANEI;

EID: 33748991694     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-006-0341-6     Document Type: Article

References (35)

1. Aharanowitz Y (1980) Nitrogen metabolite regulation of antibiotic biosynthesis. Annu Rev Microbiol 34:9-33
2. Aharanowitz Y, Demain AL (1979) Nitrogen nutrition and regulation of cephalosporin production in Streptomyces clavuligerus. Can J Microbiol 25:61-67
3. Bajapai RK, Reuß M (1981) Evaluation of feeding strategies in carbon regulated secondary metabolite production through mathematical modeling. Biotechnol Bioeng 23:739-763
4. Bapat PM, Wangikar PP (2004) Optimization of Rifamycin B fermentation in shake flasks via a machine-learning-based approach. Biotechnol Bioeng 86:201-208
5. Bapat PM, Kundu S, Wangikar PP (2003) An optimized method for Aspergillus niger spore production on natural carrier substrates. Biotech Prog 19:1683-1688
6. Bapat PM, Nandy S, Wangikar P, Venkatesh KV (2005) Quantification of metabolically active biomass using Methylene Blue dye Reduction Test (MBRT): measurement of CFU in about 200 s. J Microbiol Methods DOI 10.1016/j.mimet.2005. 06.010
7. Bapat PM, Bhartiya S, Venkatesh KV, Wangikar PP (2006) A structured kinetic model to represent the utilization of multiple substrates in complex media during rifamycin B fermentation. Biotechnol Bioeng DOI 10.1002/bit.20767
8. Bascaran V, Hardisson C, Brana A (1989) Regulation of nitrogen catebolite enzymes in Streptomyces clavuligerus. J Gen Microbiol 135:2465-2474
9. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254
10. Brana AF, Demain AL (1988) Nitrogen control of antibiotic biosynthesis in actinomycetes. In: Sanchez SE, Boca RFL (eds) Nitrogen source control of microbial processes. CRC, London, UK, pp 99-119
11. Calam CT (1987) Process development in antibiotic fermentations. University of Cambridge, Cambridge, pp 1-217
12. Dhurjati P, Ramkrishna D, Flickinger MC, Tsao GT (1985) A cybernetic view of microbial growth: modeling of cells as optimal strategists. Biotechnol Bioeng 27:1-9
13. Dynesen J, Smits HP, Olsson L, Nielsen J (1998) Carbon catabolite repression of invertase during batch cultivations of Saccharomyces cerevisiae: the role of glucose, fructose, and mannose. Appl Microbiol Biotechnol 50:579-582
14. El-Tayeb OM, Salama AA, Hussein MMM, El-Sedawy HF (2004) Optimization of industrial production of rifamycin B by Amycolatopsis mediterranei. I. The role of colony morphology and nitrogen sources in productivity. Afr J Biotechnol 3:266-272
15. Kawahuchi T, Asahi T, Satoh T, Uozumi T, Beppu T (1984) B factor, an essential regulatory substance inducing the production of rifamycin in Nocardia sp. J Antibiotics 37:1587-1595
16. Kim CG, Kirschning A, Bergon P, Zhou P, Su E, Sauerbrei B, Ning S, Ahn Y, Breuer M, Leistner E (1996) Biosynthesis of 3-amino-5-hydroxybenzoic acid, the precursor of mC(7)N units in ansamycin antibiotics. JACS 118:7486-7491
17. Kompala DS, Ramakrishna D, Tsao GT (1984) Cybernetic modelling of microbial growth in simple substrates. Biotechnol Bioeng 26:1272-1281
18. Krabben P, Theodorus D (2001) Fermentation process to produce clavulanic acid at a low concentration of free amino acids. WO Patent 00/01840
19. Martin JF, Demain AL (1980) Control of antibiotic synthesis. Microbiol Rev 44:230-251
20. Moore S (1968) Amino acid analysis: aqueous dimethyl sulfoxide as solvent for the ninhydrin reaction. J Biol Chem 243:6281-6283
21. Nielsen J (1995) Physiological engineering aspect of Penicillium chrysogenum. Polyteknisk Forlag, Lingby, Denmark
22. Pasqualucci CR, Radaelli P, Gallo GG (1970) Improved differential spectrophotometric determination of rifamycins. J Pharm Sci 59:685-687
23. Patnaik PR (2001) Penicillin fermentation: mechanisms and models for industrial-scale bioreactors. Crit Rev Microbiol 27:25-39
24. Ramakrishna R, Ramkrishna D, Konopka AE (1997) Microbial growth on substitutable substrates: characterizing the consumer-resource relationship. Biotechnol Bioeng 54:77-90
25. Ross LF, Chapital DC (1987) Simultaneous determination of carbohydrates and products of carbohydrate metabolism in fermentation mixtures by HPLC. J Chromatogr Sci 25:112-117
26. Sanchez S, Demain AL (2002) Metabolic regulation of fermentation process. Enzyme Microbiol Technol 31:895-906
27. Sensi P, Thiemann JE (1967) Production of rifamycins. Prog Ind Microbiol 6:21-59
28. Sepkowitz KA, Rafalli J, Riley L, Kiehn TE, Armstrong D (1995) Tuberculosis in the AIDS era. Clin Microbiol Rev 8:180-199
29. Stanbury PF, Whitaker A (1984) The development of inocula for industrial fermentations. In: Principles of fermentation technology. Oxford Pergamon, pp 108-119
30. Stratmann A, Schupp T, Toupet C, Schilling W, Oberer L, Traber R (2002) New insights into rifamycin B biosynthesis: isolation of proansamycin B and 34a-deoxy-rifamycin W as early macrocyclic intermediates indicating two separated biosynthetic pathways. J Antibiotics 55:396-406
31. Untrau S, Lebrihi A, Lefebvre G, Germain P (1994) Nitrogen catebolite regulation of Spiramycin production in Streptomyces ambofaciens. Curr Microbiol 28:111-118
32. Venkateswarlu G, Murali Krishna PS, Rao VL (1999) Production of rifamycin using Amycolatopsis mediterranei (MTCC14). Bioprocess Eng 20:27-30
33. Vining LC, Doull JL (1988) Catebolite repression of secondary metabolism in actinomycetes. In: Okami M (eds) 7th International symposium on Biology of Actinomycetes. Japan Scientific Societies, Tokyo, pp 406-411
34. Yu TW, Muller R, Muller M, Zhang XH, Draeger G, Kim CG, Leistner E, Floss HG (2001) Mutational analysis and reconstituted expression of the biosynthetic genes involved in the formation of 3-amino-5-hydroxybenzoic acid, the starter unit of rifamycin biosynthesis in Amycolatopsis mediterranei S699. J Biol Chem 276:12546-12555
35. Zimbro MJ, Power DA (2003) (eds) Difco and BBL manual of microbiological culture media. Becton, Dickinson and company, Maryland, USA, pp 686-687